Prosecution Insights
Prosecution Insights
11 pending office actions • 6 clients • 11 examiners • 10 art units • 0 of 11 (0%) have an AI response strategy ready • 35 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 11 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 11 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 5 (45%) |
| §102 only | 2 (18%) |
| §112 only | 3 (27%) |
| Double-patenting only | 1 (9%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DONOHUE, SEAN R | 1 | 41.5% | +21.7% |
| SEAMAN, D MARGARET M | 1 | 76.6% | +8.0% |
| ROBINSON, MIKHAIL O'DONNEL | 1 | 56.8% | +41.6% |
| FETTEROLF, BRANDON J | 1 | 49.5% | +14.6% |
| MOTEVALLI, OROD | 1 | — | — |
| HABTE, KAHSAY | 1 | 84.9% | +7.3% |
| DICKENS, AMELIA NICOLE | 1 | 48.2% | +22.6% |
| YANG, JIE | 1 | 62.2% | +19.0% |
| WANG, NICHOLAS A | 1 | 53.9% | +21.9% |
| SU, XIAOWEI | 1 | 71.3% | +12.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18263702 | SUBSTITUTED PYRIDAZINE PHENOL DERIVATIVES | HABTE, KAHSAY | 62d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17927139 | A LIVE STRAIN OF STAPHYLOCOCCUS AUREUS AND USES THEREOF | DICKENS, AMELIA NICOLE | 131d overdue |
| 17635156 | R-T-B SERIES PERMANENT MAGNET MATERIAL, RAW MATERIAL COMPOSITION, PREPARATION METHOD AND APPLICATION | WANG, NICHOLAS A | 45d overdue |
| 17600105 | NEODYMIUM-IRON-BORON MAGNET MATERIAL, RAW MATERIAL COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF | SU, XIAOWEI | 42d overdue |
| 18550468 | 6-CARBAMATE SUBSTITUTED HETEROARYL RING DERIVATIVES | FETTEROLF, BRANDON J | 16d overdue |
| 18505192 | NAPHTHALENE RING-CONTAINING COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF | ROBINSON, MIKHAIL O'DONNEL | 8d |
| 18729913 | PEPTIDE UREA DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING PEPTIDE UREA DERIVATIVE, AND APPLICATION OF PEPTIDE UREA DERIVATIVE | DONOHUE, SEAN R | 75d |
| 17787283 | NEODYMIUM-IRON-BORON PERMANENT MAGNET MATERIAL, PREPARATION METHOD, AND APPLICATION | YANG, JIE | 86d |
| Client (Assignee) | Pending OAs |
|---|---|
| Xiamen Tungsten | 4 |
| MEDSHINE DISCOVERY INC. | 3 |
| Bivision Pharmaceuticals, Inc. | 1 |
| Jiangxi Kerui Pharmaceutical Co., Ltd. | 1 |
| Asieris Pharmaceuticals | 1 |
| VERSITECH LIMITED | 1 |
| Art Unit | Apps |
|---|---|
| 1734 | 2 |
| 1618 | 1 |
| 1625 | 1 |
| 1627 | 1 |
| 1626 | 1 |
| 1628 | 1 |
| 1624 | 1 |
| 1645 | 1 |
| 1733 | 1 |
| 1735 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18729913 | PEPTIDE UREA DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING PEPTIDE UREA DERIVATIVE, AND APPLICATION OF PEPTIDE UREA DERIVATIVE | Bivision Pharmaceuticals, Inc. | DONOHUE, SEAN R | 1618 | §103 | Final Rejection | 75d | Pending | Jul 18, 2024 |
| 18556376 | RETINOIC ACID RECEPTOR AGONIST, PREPARATION METHOD THEREFOR, INTERMEDIATE, PHARMACEUTICAL COMPOSITION AND USE | Jiangxi Kerui Pharmaceutical Co., Ltd. | SEAMAN, D MARGARET M | 1625 | §103 | Non-Final OA | 40d | Pending | Jan 18, 2024 |
| 18505192 | NAPHTHALENE RING-CONTAINING COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF | Asieris Pharmaceuticals (Shanghai) Co., Ltd. | ROBINSON, MIKHAIL O'DONNEL | 1627 | §112 | Non-Final OA | 8d | Pending | Nov 09, 2023 |
| 18550468 | 6-CARBAMATE SUBSTITUTED HETEROARYL RING DERIVATIVES | Medshine Discovery Inc. | FETTEROLF, BRANDON J | 1626 | §112 | Non-Final OA | 16d overdue | Pending | Sep 14, 2023 |
| 18549366 | BICYCLIC PHENOL COMPOUNDS AND USE THEREOF | Medshine Discovery Inc. | MOTEVALLI, OROD | 1628 | §112 | Non-Final OA | 21d | Pending | Sep 07, 2023 |
| 18263702 | SUBSTITUTED PYRIDAZINE PHENOL DERIVATIVES | Medshine Discovery Inc. | HABTE, KAHSAY | 1624 | §102 | Non-Final OA | 62d | Pending | Jul 31, 2023 |
| 17927139 | A LIVE STRAIN OF STAPHYLOCOCCUS AUREUS AND USES THEREOF | VERSITECH LIMITED | DICKENS, AMELIA NICOLE | 1645 | §102 | Final Rejection | 131d overdue | Pending | Nov 22, 2022 |
| 17787283 | NEODYMIUM-IRON-BORON PERMANENT MAGNET MATERIAL, PREPARATION METHOD, AND APPLICATION | Fujian Golden Dragon Rare-Earth Co., Ltd. | YANG, JIE | 1734 | DP | Non-Final OA | 86d | Pending | Jun 17, 2022 |
| 17635156 | R-T-B SERIES PERMANENT MAGNET MATERIAL, RAW MATERIAL COMPOSITION, PREPARATION METHOD AND APPLICATION | Fujian Golden Dragon Rare-Earth Co., Ltd. | WANG, NICHOLAS A | 1734 | §103 | Final Rejection | 45d overdue | Pending | Feb 14, 2022 |
| 17600105 | NEODYMIUM-IRON-BORON MAGNET MATERIAL, RAW MATERIAL COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF | Fujian Golden Dragon Rare-Earth Co., Ltd. | SU, XIAOWEI | 1733 | §103 | Final Rejection | 42d overdue | Pending | Sep 30, 2021 |
| 17600107 | RTB-Based Permanent Magnet Material, Preparation Method thereof, and Application thereof | Fujian Golden Dragon Rare-Earth Co., Ltd. | HILL, STEPHANI A | 1735 | §103 | Final Rejection | 42d overdue | Pending | Sep 30, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial